SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-036257
Filing Date
2020-08-05
Accepted
2020-08-04 18:54:46
Documents
5
Period of Report
2020-08-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K FOR ATM UPSIZE flgt-8k_20200804.htm 8-K 33614
2 EX-1.1 flgt-ex11_7.htm EX-1.1 15773
3 EX-5.1 flgt-ex51_6.htm EX-5.1 15297
4 GRAPHIC ggihruwlttof000001.jpg GRAPHIC 10797
5 GRAPHIC ggihruwlttof000002.jpg GRAPHIC 8006
  Complete submission text file 0001564590-20-036257.txt   92100
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37894 | Film No.: 201074896
SIC: 8071 Services-Medical Laboratories